glipizide has been researched along with glucagon in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (45.00) | 18.7374 |
| 1990's | 8 (40.00) | 18.2507 |
| 2000's | 2 (10.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lecomte, MJ; Lefebvre, PJ; Luyckx, AS | 1 |
| Avery, GS; Brogden, RN; Heel, RC; Pakes, GE; Speight, TM | 1 |
| Lu, ZN; Selawry, HP; Solomon, SS; Whittington, KB | 1 |
| Barr, JD; Cornett, G; Flanagan, TL; Freedlender, AE; Hanks, JB; Kaiser, DL; Parish, ES | 1 |
| Reckless, JP; Simpson, HC; Stirling, CA; Sturley, R | 1 |
| Barr, JD; Farris, AH; Freedlender, AH; Hanks, JB; Kaiser, DL; Krusch, DA; Parish, ES | 1 |
| DeFronzo, RA; Groop, L; Groop, PH; Luzi, L; Melander, A; Ratheiser, K; Simonson, DC | 1 |
| Ahrén, B; Lundquist, I; Scherstén, B | 1 |
| Fyhrqvist, F; Groop, L; Groop, PH; Melander, A; Tolppanen, EM; Tötterman, KJ; Wåhlin-Boll, E | 1 |
| Neuvonen, PJ; Pentikäinen, PJ; Penttilä, A | 1 |
| de la Viña, S; Nash Raina, RE; Ordoñez Pérez, AJ; Sánchez Arriarán, MS; Serrano Ríos, M; Villalba Díaz, MT | 1 |
| de la Viña, S; Nash, RE; Ordóñez, AJ; Sánchez, MS; Serrano, M; Villalba, MT | 1 |
| Berlin, I; Blacker, C; Cesselin, F; Chalon, S; Fuseau, E; Landault, C; Puech, AJ; Rosenzweig, P | 1 |
| Andersen, PH; Bak, JF; Christiansen, JS; Lund, S; Møller, N; Orskov, L; Pedersen, O; Rasmussen, O; Schmitz, O | 1 |
| Albert, SG; Bernbaum, M; Mooradian, AD; Plummer, S | 1 |
| Anderson, BD; Anderson, DL; Fenn, J; Gorman, SE; Krenzelok, EP; Muir, SJ; Rodgers, GC; Rose, SR; Spiller, HA; Villalobos, D | 1 |
| Slover-Zipf, J | 1 |
| de Souza, CJ; Dunning, BE; Lozito, R; Russo, P | 1 |
| Eiermann, GJ; Feng, Y; Howard, AD; Li, C; Li, Z; Mu, J; Petrov, A; Roy, RS; Thornberry, NA; Woods, J; Zhang, BB; Zhou, YP; Zhu, L; Zycband, E | 1 |
| Chamarthi, B; Chen, L; Florez, JC; Goldfine, A; Hudson, M; Kaur, V; Littleton, KR; Manning, AK; Merino, J; Srinivasan, S; Thomas, MK | 1 |
1 review(s) available for glipizide and glucagon
| Article | Year |
|---|---|
Glipizide: a review of its pharmacological properties and therapeutic use.
Topics: Animals; Diabetes Mellitus; Fatty Acids; Glipizide; Glucagon; Humans; Hypoglycemic Agents; Kinetics; Sulfonylurea Compounds | 1979 |
5 trial(s) available for glipizide and glucagon
| Article | Year |
|---|---|
Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.
Topics: Adult; Aged; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Fatty Acids, Nonesterified; Female; Glipizide; Glucagon; Humans; Insulin; Male; Middle Aged; Placebos; Sulfonylurea Compounds | 1977 |
Combination of insulin with glipizide increases peripheral glucose disposal in secondary failure type 2 diabetic patients.
Topics: Aged; Blood Glucose; C-Peptide; Cholesterol; Cholesterol Esters; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glipizide; Glucagon; Glucose Clamp Technique; Glyburide; Glycated Hemoglobin; Humans; Insulin; Lipoproteins; Male; Middle Aged; Sulfonylurea Compounds | 1990 |
Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics.
Topics: Aged; Blood Glucose; Body Weight; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Erythrocytes; Female; Gastric Inhibitory Polypeptide; Glipizide; Glucagon; Glyburide; Glycosuria; Humans; Insulin; Insulin Resistance; Kinetics; Male; Middle Aged; Random Allocation; Sulfonylurea Compounds | 1985 |
Reduction of hyperglycemia after oral glucose load by the new alpha 2-adrenergic receptor antagonist SL 84.0418 in healthy subjects.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Blood Glucose; C-Peptide; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Glipizide; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Indoles; Insulin; Male; Pyrroles; Reference Values | 1994 |
The effect of glipizide gastrointestinal therapeutic system on islet cell hormonal responses to a test meal in NIDDM.
Topics: Amyloid; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Double-Blind Method; Eating; Fasting; Female; Glipizide; Glucagon; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Male; Middle Aged; Placebos; Postprandial Period; Single-Blind Method | 1996 |
14 other study(ies) available for glipizide and glucagon
| Article | Year |
|---|---|
Islet allografts in the cryptorchid testes of spontaneously diabetic BB/Wor dp rats: response to glucose, glipizide, and arginine.
Topics: Animals; Arginine; Cryptorchidism; Diabetes Mellitus, Type 1; Glipizide; Glucagon; Glucose; Glucose Tolerance Test; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Male; Rats; Rats, Inbred BB; Testis | 1991 |
Glipizide treatment of pancreas autotransplantation: effects on alterations in glucose-insulin relationships.
Topics: Animals; Blood Glucose; Dogs; Female; Glipizide; Glucagon; Glucose Tolerance Test; Insulin; Pancreas Transplantation; Transplantation, Autologous | 1991 |
Effect of glipizide on the surgically altered pancreas.
Topics: Animals; Dogs; Female; Glipizide; Glucagon; Glucose; Glucose Tolerance Test; Insulin; Pancreas; Pancreatectomy; Sulfonylurea Compounds | 1989 |
Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Gastric Inhibitory Polypeptide; Glipizide; Glucagon; Glucose; Glyburide; Humans; Hyperglycemia; Insulin; Insulin Secretion; Kinetics; Liver; Sulfonylurea Compounds | 1987 |
Effects of glipizide on various consecutive insulin secretory stimulations in patients with type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 2; Drug Interactions; Female; Food; Glipizide; Glucagon; Glucose; Humans; Insulin; Insulin Secretion; Male; Middle Aged; Sulfonylurea Compounds; Terbutaline | 1986 |
Pharmacokinetics and pharmacodynamics of glipizide in healthy volunteers.
Topics: Administration, Oral; Adult; Biological Availability; Blood Glucose; Female; Glipizide; Glucagon; Humans; Injections, Intravenous; Insulin; Kinetics; Male; Middle Aged; Sulfonylurea Compounds; Time Factors | 1983 |
[Mechanism of action of sulfonylureas at the pancreatic and extra-pancreatic levels in prolonged treatment in noninsulin-dependent diabetic patients].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Erythrocytes; Female; Glipizide; Glucagon; Glycated Hemoglobin; Humans; Insulin; Male; Middle Aged; Sulfonylurea Compounds | 1983 |
[Long-term effects of glipizide at the pancreatic and extra-pancreatic level in non-insulin dependent diabetics].
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Erythrocytes; Female; Glipizide; Glucagon; Glycated Hemoglobin; Humans; Insulin; Islets of Langerhans; Male; Middle Aged; Receptor, Insulin; Sulfonylurea Compounds | 1984 |
Effects of glipizide on glucose metabolism and muscle content of the insulin-regulatable glucose transporter (GLUT 4) and glycogen synthase activity during hyperglycaemia in type 2 diabetic patients.
Topics: Adult; Biopsy; Blood Glucose; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Female; Glipizide; Glucagon; Glucose; Glucose Clamp Technique; Glucose Transporter Type 4; Glycogen Synthase; Humans; Hyperglycemia; Male; Middle Aged; Monosaccharide Transport Proteins; Muscle Proteins; Muscles | 1994 |
Prospective multicenter study of sulfonylurea ingestion in children.
Topics: Accidents; Administration, Oral; Blood Glucose; Body Weight; Child; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Drug Monitoring; Female; Forecasting; Gastrointestinal Agents; Glipizide; Glucagon; Glucose; Glyburide; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Infant; Infusions, Intravenous; Male; Patient Admission; Poison Control Centers; Prospective Studies; Risk Factors; Sensitivity and Specificity; Sulfonylurea Compounds; Time Factors; Treatment Outcome | 1997 |
Hypoglycemia treatment.
Topics: Administration, Oral; Carbohydrates; Drug Combinations; Gastrointestinal Agents; Glipizide; Glucagon; Humans; Hypoglycemia; Hypoglycemic Agents; Phytotherapy | 1999 |
Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions.
Topics: Animals; Blood Glucose; Carbamates; Cyclohexanes; Food; Glipizide; Glucagon; Insulin; Insulin Secretion; Male; Nateglinide; Phenylalanine; Piperidines; Rats; Rats, Sprague-Dawley | 2001 |
Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fats; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glipizide; Glucagon; Glucagon-Like Peptide 1; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Insulin Secretion; Islets of Langerhans; Ki-67 Antigen; Lipids; Liver; Male; Mice; Mice, Inbred ICR; Organ Size; Pyrazines; Sitagliptin Phosphate; Triazoles; Triglycerides | 2009 |
Topics: Adult; Aged; Alleles; Blood Glucose; Diabetes Mellitus, Type 2; Female; Genotyping Techniques; Glipizide; Glucagon; Glucagon-Like Peptide 1; Glucose Tolerance Test; Humans; Incretins; Male; Metformin; Middle Aged; Polymorphism, Single Nucleotide; Prospective Studies; Retrospective Studies; Risk Factors; Sulfonylurea Compounds; Transcription Factor 7-Like 2 Protein | 2018 |